Keyphrases
NADPH Oxidase
100%
NADPH Oxidase 2 (NOX2)
100%
Angiotensin II-induced Hypertension
100%
Vasomotor Symptoms
100%
Angiotensin II (Ang II)
42%
Blood Pressure
28%
Hypertension
28%
Endothelial Function
28%
Endothelial Dysfunction
28%
Reactive Oxygen Species
14%
Reactive Oxygen Species Production
14%
Overexpression
14%
Endothelium
14%
High Dose
14%
Endothelial Nitric Oxide Synthase (eNOS)
14%
Acetylcholine
14%
Littermate
14%
Transgenic Mice
14%
Vasorelaxation
14%
Vascular Remodeling
14%
Vessel Wall
14%
Angiotensin II Infusion
14%
NADPH Oxidase Activity
14%
Aortic Remodeling
14%
Ambulatory Blood Pressure
14%
Aorta
14%
P22phox
14%
Medicine and Dentistry
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
100%
Angiotensin II
100%
Vasomotor
100%
Reactive Oxygen Species
33%
Blood Pressure
33%
Endothelial Function
33%
Endothelial Dysfunction
33%
Infusion
16%
Vasodilatation
16%
Low Drug Dose
16%
Endothelial Nitric Oxide Synthase
16%
Acetylcholine
16%
Drug Megadose
16%
Transgenic Mouse
16%
Ambulatory Blood Pressure
16%
Vascular Remodeling
16%
Neuroscience
Angiotensin II
100%
NADPH Oxidase
100%
Vasomotor
100%
Hypertension
100%
Reactive Oxygen Species
33%
In Vivo
16%
Acetylcholine
16%
Endothelial Nitric Oxide Synthase
16%
Biochemistry, Genetics and Molecular Biology
Angiotensin
100%
NAD(P)H Oxidase
100%
Wild Type
50%
Blood Pressure
50%
Isoform
33%
Low Drug Dose
16%
Drug Megadose
16%
Nitric Oxide Synthase
16%
Transgenic Mouse
16%
Vasodilatation
16%
Acetylcholine
16%
P22phox
16%
Pharmacology, Toxicology and Pharmaceutical Science
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
100%
Angiotensin II
100%
Reactive Oxygen Metabolite
33%
Endothelial Dysfunction
33%
Endothelial Nitric Oxide Synthase
16%
Acetylcholine
16%
Transgenic Mouse
16%
Vascular Remodeling
16%